Peter Carmeliet
The Center for Transgene Technology and Gene Therapy
Flanders Interuniversity Institute for Biotechnology
Leuven
Belgium
Name/email consistency: high
- Manipulating angiogenesis in medicine. Carmeliet, P. J. Intern. Med. (2004)
- De novo vasculogenesis in the heart. Luttun, A., Carmeliet, P. Cardiovasc. Res. (2003)
- Angiogenesis in health and disease. Carmeliet, P. Nat. Med. (2003)
- Blood vessels and nerves: common signals, pathways and diseases. Carmeliet, P. Nat. Rev. Genet. (2003)
- Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Carmeliet, P., Storkebaum, E. Semin. Cell Dev. Biol. (2002)
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K.H., Foidart, J.M., Schaper, W., Charnock-Jones, D.S., Hicklin, D.J., Herbert, J.M., Collen, D., Persico, M.G. Nat. Med. (2001)
- The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis. Carmeliet, P., Luttun, A. Thromb. Haemost. (2001)
- Transgenic mouse models in angiogenesis and cardiovascular disease. Carmeliet, P., Collen, D. J. Pathol. (2000)
- Mechanisms of angiogenesis and arteriogenesis. Carmeliet, P. Nat. Med. (2000)
- Proteinases in cardiovascular aneurysms and rupture: targets for therapy?. Carmeliet, P. J. Clin. Invest. (2000)
- Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Carmeliet, P., Collen, D. Ann. N. Y. Acad. Sci. (2000)
- Angiogenesis in cancer and other diseases. Carmeliet, P., Jain, R.K. Nature (2000)
- Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Carmeliet, P., Ng, Y.S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V.V., Stalmans, I., Mattot, V., Perriard, J.C., Dewerchin, M., Flameng, W., Nagy, A., Lupu, F., Moons, L., Collen, D., D'Amore, P.A., Shima, D.T. Nat. Med. (1999)
- Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. Carmeliet, P., Moons, L., Dewerchin, M., Rosenberg, S., Herbert, J.M., Lupu, F., Collen, D. J. Cell Biol. (1998)
- Vascular development and disorders: molecular analysis and pathogenic insights. Carmeliet, P., Collen, D. Kidney Int. (1998)
- Tissue factor. Carmeliet, P., Collen, D. Int. J. Biochem. Cell Biol. (1998)
- Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Carmeliet, P., Dor, Y., Herbert, J.M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C.J., Ratcliffe, P., Moons, L., Jain, R.K., Collen, D., Keshert, E., Keshet, E. Nature (1998)
- Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis. Carmeliet, P., Moons, L., Collen, D. Cardiovasc. Res. (1998)
- Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Carmeliet, P., Collen, D. Thromb. Res. (1998)